Changes in gene expression and morphology of mouse embryonic stem cells on differentiation into insulin-producing cells in vitro and in vivo

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 5, 2009, Pages 464-476

  Naujok, Ortwin ^a   Francini, Flavio ^a   Picton, Sally ^b   Bailey, Clifford J ^b   Lenzen, Sigurd ^a   Jörns, Anne ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

Differentiation; Insulin cell therapy; Insulin producing cells; Mouse embryonic stem cells

Indexed keywords

AMYLIN; GLUCOKINASE; GLUCOSE TRANSPORTER 2; INSULIN; NESTIN; TRANSCRIPTION FACTOR PDX 1; AMYLOID; BIOLOGICAL MARKER; HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; INTERMEDIATE FILAMENT PROTEIN; NERVE PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CELL MATURATION; CELL SPECIFICITY; CELL STRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; THERAPY EFFECT; ANIMAL; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; METHODOLOGY; PHYSIOLOGY; TRANSPLANTATION;

AMYLOID; ANIMALS; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOKINASE; GLUCOSE TRANSPORTER TYPE 2; HOMEODOMAIN PROTEINS; INSULIN; INSULIN-SECRETING CELLS; INTERMEDIATE FILAMENT PROTEINS; MALE; MICE; NERVE TISSUE PROTEINS; STEM CELL TRANSPLANTATION; TRANS-ACTIVATORS;

EID: 70350637529     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.965     Document Type: Article

References (33)

1. Newgard CB. Cellular engineering and gene therapy strategies for insulin replacement in diabetes. Diabetes 1994; 43: 341-350. (Pubitemid 24064239)
2. Naujok O, Francini F, Jörns A, et al. An efficient experimental strategy for mouse embryonic stem cell differentiation and separation of a cytokeratin-19-positive population of insulin-producing cells. Cell Prolif 2008; 41: 607-624.
3. D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006; 24: 1392-1401. (Pubitemid 44722103)
4. Shim JH, Kim SE, Woo DH, et al. Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia 2007; 50: 1228-1238. (Pubitemid 46701546)
5. Lumelsky N, Blondel O, Laeng P, et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001; 292: 1389-1394. (Pubitemid 32476228)
6. Naujok O, Francini F, Picton S, et al. A new experimental protocol for preferential differentiation of mouse embryonic stem cells into insulin-producing cells. Cell Transplantation 2008;; (in press).
7. Ahlgren U, Jonsson J, Jonsson L, et al. beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998; 12: 1763-1768. (Pubitemid 28304328)
8. Rajagopal J, Anderson WJ, Kume S, et al. Insulin staining of ES cell progeny from insulin uptake. Science 2003; 299(:): 363. (Pubitemid 36120032)
9. Johnson KH, O'Brien TD, Hayden DW, et al. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol 1988; 130: 1-8.
10. Meglasson MD, Matschinsky FM. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev 1986; 2: 163-214. (Pubitemid 16009507)
11. Lenzen S, Panten U. Signal recognition by pancreatic B-cells. Biochem Pharmacol 1988; 37: 371-378.
12. Jörns A, Tiedge M, Lenzen S. Nutrient-dependent distribution of insulin and glucokinase immunoreactivities in rat pancreatic beta cells. Virchows Arch 1999; 434: 75-82. (Pubitemid 29184906)
13. Watada H, Kajimoto Y, Umayahara Y, et al. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes 1996; 45: 1478-1488. (Pubitemid 26357538)
14. Doetschman TC, Eistetter H, Katz M, et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 1985; 87: 27-45. (Pubitemid 15029925)
15. Jörns A, Rath KJ, Bock O, et al. Beta cell death in hyperglycaemic Psammomys obesus is not cytokine-mediated. Diabetologia 2006; 49: 2704-2712.
16. Hsu SM, Raine L. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 1981; 29: 1349-1353.
17. Morel G, Berger M, Ronsin B, et al. In situ reverse transcription- polymerase chain reaction. Applications for light and electron microscopy. Biology of the Cell/under the auspices of the European Cell Biology Organization 1998; 90: 137-154. (Pubitemid 28302145)
18. Bagasra O, Michaels FH, Zheng YM, et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci U S A 1995; 92: 12041-12045. (Pubitemid 26014007)
19. Williams RL, Hilton DJ, Pease S, et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988; 336: 684-687. (Pubitemid 19007951)
20. Sipione S, Eshpeter A, Lyon JG, et al. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 2004; 47: 499-508. (Pubitemid 38491246)
21. Gao R, Ustinov J, Korsgren O, et al. In vitro neogenesis of human islets reflects the plasticity of differentiated human pancreatic cells. Diabetologia 2005; 48: 2296-2304. (Pubitemid 41618921)
22. Blyszczuk P, Asbrand C, Rozzo A, et al. Embryonic stem cells differentiate into insulin-producing cells without selection of nestin-expressing cells. Int J Dev Biol 2004; 48: 1095-1104. (Pubitemid 40179576)
23. Blyszczuk P, Czyz J, Kania G, et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci U S A 2003; 100: 998-1003. (Pubitemid 36183944)
24. Hori Y, Rulifson IC, Tsai BC, et al. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 2002; 99: 16105-16110. (Pubitemid 35462756)
25. Shi Y, Hou L, Tang F, et al. Inducing embryonic stem cells to differentiate into pancreatic beta cells by a novel three-step approach with activin A and all-trans retinoic acid. Stem Cells 2005; 23: 656-662. (Pubitemid 40647262)
26. Jiang J, Au M, Lu K, et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007; 25: 1940-1953. (Pubitemid 47258172)
27. Soria B, Roche E, Berna G, et al. Insulin-secreting cells derived fromembryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000; 49: 157-162. (Pubitemid 30070992)
28. Leon-Quinto T, Jones J, Skoudy A, et al. In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 2004; 47: 1442-1451. (Pubitemid 39232431)
29. Fujikawa T, Oh SH, Pi L, et al. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 2005; 166: 1781-1791. (Pubitemid 40734401)
30. Ahlgren U, Jonsson J, Edlund H. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 1996; 122: 1409-1416. (Pubitemid 26159631)
31. Jonsson J, Ahlgren U, Edlund T, et al. IPF1, a homeodomain protein with a dual function in pancreas development. Int J Dev Biol 1995; 39: 789-798. (Pubitemid 26056347)
32. Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008; 26: 443-452.
33. Hansson M, Tonning A, Frandsen U, et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes 2004; 53: 2603-2609. (Pubitemid 39299268)